Combination of PARP and WEE1 inhibitors in vitro: Potential for use in the treatment of SHH medulloblastoma

por Lukoseviciute, Monika, Theodosopoulou, Aikaterini, Holzhauser, Stefan, Dalianis, Tina, Kostopoulou, Ourania N.
Publicado 2023

Efficacy of combined targeted therapy with PI3K and CDK4/6 or PARP and WEE1 inhibitors in neuroblastoma cell lines

por Lukoseviciute, Monika, Holzhauser, Stefan, Pappa, Eleni, Mandal, Tamoghna, Dalianis, Tina, Kostopoulou, Ourania N.
Publicado 2023

Targeted Therapy with PI3K, PARP, and WEE1 Inhibitors and Radiotherapy in HPV Positive and Negative Tonsillar Squamous Cell Carcinoma Cell Lines Reveals Synergy while Effects with...

por Byskata, Karin, Lukoseviciute, Monika, Tuti, Filippo, Zupancic, Mark, Kostopoulou, Ourania N., Holzhauser, Stefan, Dalianis, Tina
Publicado 2022

Targeting PI3K, FGFR, CDK4/6 Signaling Pathways Together With Cytostatics and Radiotherapy in Two Medulloblastoma Cell Lines

por Lukoseviciute, Monika, Maier, Henrietta, Poulou-Sidiropoulou, Eleni, Rosendahl, Erika, Holzhauser, Stefan, Dalianis, Tina, Kostopoulou, Ourania N.
Publicado 2021

Effects of PI3K and FGFR inhibitors alone and in combination, and with/without cytostatics in childhood neuroblastoma cell lines

por Holzhauser, Stefan, Lukoseviciute, Monika, Papachristofi, Christina, Vasilopoulou, Christina, Herold, Nikolas, Wickström, Malin, Kostopoulou, Ourania N., Dalianis, Tina
Publicado 2021

Targeted Therapy of HPV Positive and Negative Tonsillar Squamous Cell Carcinoma Cell Lines Reveals Synergy between CDK4/6, PI3K and Sometimes FGFR Inhibitors, but Rarely between PA...

por Kostopoulou, Ourania N., Zupancic, Mark, Pont, Mariona, Papin, Emma, Lukoseviciute, Monika, Mikelarena, Borja Agirre, Holzhauser, Stefan, Dalianis, Tina
Publicado 2022